Activity of cathepsin B and D in colorectal cancer: Relationships with tumour budding

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 2847-2851

  Guzińska Ustymowicz, Katarzyna ^a   Zalewski, Bogdan ^a   Kasacka, Irena ^a   Piotrowski, Zdzisław ^a   Skrzydlewska, Elz̀bieta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cathepsin B; Cathepsin D; Colorectal cancer; Tumour budding

Indexed keywords

CATHEPSIN B; CATHEPSIN D;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE HOMOGENATE;

ADULT; AGED; AGED, 80 AND OVER; CATHEPSIN B; CATHEPSIN D; COLON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RECTUM;

EID: 6444238769     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Rochefort H: Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer 28A: 1780-1783, 1992.
2. Lah TT, Kalman E, Najjar D, Gorodetsky E, Brennan P, Somers R and Daskal I: Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis. Hum Pathol 31: 149-160, 2000.
3. Frosch BA, Berquin I, Emmert-Buck MR, Moin K and Solane BF: Molecular regulation, membrane association and secretion of tumor cathepsin B. APMIS 107: 28-37, 1999.
4. Van der Stappen JWJ, Wiliwms AC, Maciewicz RA and Paraskeva C: Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Cancer 67: 547-554, 1996.
5. Bercham G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M and Liaudet-Coopman E: Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21: 5951-5955, 2002.
6. Krepela E: Cysteine proteinases in tumor cell growth and apoptosis. Neoplasma 48: 332-349, 2001.
7. Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM and Zacharias W: Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum Pathol 32: 931-937, 2000.
8. Dohchin A, Suzuki JI, Seki H, Masutani M, Shiroto H and Kawakami Y: Immunostained cathepsin B and L correlate with depth of and different metastatic pathways in early stage gastric carcinoma. Cancer 89: 482-487, 2000.
9. Murnane MJ, Sheahan K, Ozdemirli M and Shuja S: Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res 57: 1137-1142, 1991.
10. Hughes SJ, Glover TW, Zhu XX, Kuick R, Thoraval D, Orringer MB, Beer DG and Hanash S: A novel amplication at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc Natl Acad Sci USA 95: 12410-12415, 1998.
11. Rempel SA, Rosenblum ML, Mikkelsen T, Yan PS, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Zeigler G and Solane BF: Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 54: 6027-6031, 1994.
12. Hazen LGM, Bleeker FE, Lauritzen B, Bahns S, Song J, Jonker A, Van Driel Bem, Lyon H, Hansen U, Kohler A and Van Noorden CJF: Comparative localization of cathepsin B protein and activity in colorectal cancer. J Histochem Cytochem 48: 1421-1430, 2000.
13. Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K and Morimatsu M: An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancers. Cancer 63: 539-543, 1989.
14. Jass R, Barer M, Fraser L, Walsh MD, Whitehall VLJ, Gabrielli B, Young J and Leggett BA: APC mutation and tumour budding in colorectal cancer. J Clin Pathol 56: 69-73, 2003.
15. Hase K, Shatney C, Johnson D, Trollope M and Vierra M: Prognostic value of tumour "budding" in patients with colorectal cancer. Dis Colon Rectum 36: 627-635, 1993.
16. Hase K, Shatney CH, Mochizuki H, Johnson DL, Tamakuma S, Vierra M and Trollope M: Long-term results of curative resection of 'minimally invasive' colorectal cancer. Dis Colon Rectum 38: 19-26, 1995.
17. Ueno H, Murphy J, Jass JR, Mochizuki H and Talbot IC: Tumour budding as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40: 127-132, 2002.
18. Tanaka M, Hashiguchi Y, Ueno H, Hase K and Mochizuki H: Tumour budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum 46: 1054-1059, 2003.
19. Okuyama T, Oya M and Ishikawa H: Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal carcinoma. Dis Colon Rectum 45: 628-634, 2002.
20. Masaki T, Matsuoka H, Sugiyama M, Abe N, Mori T, Atomi Y, Watanabe T, Nagawa H and Muto T: Budding as a useful determinant of the optimal treatment for T1 rectal carcinomas. Hepatogastroenterol 50: 388-391, 2003.
21. Masaki T, Matsuoka H, Sugiyama M, Abe N, Izumisao Y, Goto A, Sakamoto A and Atomi Y: Lamina-5 gamma 2 chain and matrix metalloproteinase-2 may trigger colorectal carcinoma invasiveness through formation of budding tumor cells. Anticancer Res 23: 4113-4119, 2003.
22. Tawatari T, Kawabata Y and Katunuma M: Crystalization and properties of cathepsin B from rat liver. Eur J Biochem 102: 279-289, 1979.
23. Barrett AJ: Cathepsin D and other carboxyl proteinases in: Barrett AJ, Proteinases in Mammalian Cells and Tissues. North-Holland Publishing Company, 1977, pp240-243.
24. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ: Protein measurement with Folin phenol reagent. J Biol Chem 153: 265-275, 1951.
25. Rochefort H, Garcia M, Glondu M, Laurent V, Liaudet E, Rey JM and Roger P: Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin Chim Acta 291: 157-170, 2000.
26. Oh-e H, Tanaka S, Kitadai Y, Shimamoto F, Yoshihara M and Haruma K: Cathepsin D expression as a possible predictor of lymph node metastasis in submucosal colorectal cancer. Eur J Cancer 37: 180-188, 2001.
27. Ikeguchi M, Fukuda K, Oka S, Yamaguchi K, Hisamitsu K, Tsujitani S, Sakatani T, Ueda T and Kaibara N: Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma. Oncology 61: 71-78, 2001.
28. Ioachim E, Charchanti A, Stavropoulos N, Athanassiou E, Bafa M and Agnantis NJ: Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices. Anticancer Res 22: 3383-3388, 2002.
29. Ioachim E, Goussia AC, Machera M, Tsianos EV, Kappas AM and Agnantis NJ: Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices. Anticancer Res 19: 2147-2156, 1999.
30. Guzinska-Ustymowicz K, Sulkowska M, Famulski W and Sulkowski S: Tumour budding and its relationsip to p53 and Bcl-2 expression in colorectal cancer. Anticancer Res 23: 649-654, 2003.
31. Gabbert H: Mechanisms in tumor invasion: evidence from in vivo observations. Cancer Metastasis Rev 4: 293-309, 1985.
32. Masaki T, Matsuoka H, Sugiyama M, Abe N, Goto A, Sakamoto A and Atomi Y: Matrylisin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 84: 1317-21, 2001.
33. Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M and Peyral JB: Cathepsins B, L, and D activities in colorectal carcinomas: relationship with clinic-pathological parameters. Cancer Left 96: 267-275, 1995.
34. Saku T, Sakai H, Tsuda N, Okabe H, Kato Y and Yamamoto K: Cathepsin D and E in normal, metaplastic, dysplastic and carcinomatous gastric tissue: an immunohistochemical study. Gut 31: 1250-1255, 1990.
35. Famulski W, Guzinska-Ustymowicz, Sulkowska M, Chabowski A, Zalewski B, Piotrowski Z, Stasiak-Barmuta A and Sulkowski S: Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer. Folia Histochem Cytobiol 39(Suppl. 2): 171-172, 2001.
36. Shuja S and Murnane MJ: Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease. Int J Cancer 66: 420-426, 1996.
37. Sinha AA, Gleason DF, Deleon OF, Wilson MJ and Sloane BF: Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat Rec 235: 233-240, 1993.
38. Buck MR, Karustis DG, Day NA, Honn KV and Solane BF: Degradation of extracellular-matrix proteins by human cathepsins B from normal and tumor tissues. Biochem J 282: 273-277, 1992.
39. Guinec N, Pagano M, Dalet-Fumeron V and Engler R: In vitro digestion of intact bovine lens capsules by four human lysosomes cysteine-proteinases. Biol Chem Hoppe-Seyler 371: 239-254, 1990.
40. Solane BF, Moin K, Sameni M, Tait LR, Rozhin J and Ziegler G: Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Sci 107: 420-426, 1994.
41. Campo E, Munoz J, Nadal A, Jares P, Fernandez PL, Pakein A, Emmert-Buck M, Solane B and Cardesa A: Cathepsin B mRNA overexpression correlated with tumor progression in colorectal carcinomas. Lab Invest 72: A58, 1995.